Skip to content

Clinical trials

Phase 3 Cytomegalovirus Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cytomegalovirus Infections Phase: Phase 3 Country / region: United States Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20041
20062
20071
20081
20121
20152
20191
20211
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)7
Jazz Pharmaceuticals2
Shire2
Astra USA1
Duke University1
Hoffmann-La Roche1
Merck Sharp & Dohme LLC1
ModernaTX, Inc.1
New York Medical College1
Schering-Plough1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cytomegalovirus Infections21
HIV Infections7
Acquired Immunodeficiency Syndrome5
Multiple Acyl Coenzyme A Dehydrogenase Deficiency4
Cytomegalovirus Retinitis3
Retinitis3
AIDS-Related Opportunistic Infections2
Adenoviridae Infections1
DNA Virus Infections1
Gastrointestinal Diseases1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.